Cargando…

Correction: The Role of Anticoagulation in Treating Portal Hypertension

Detalles Bibliográficos
Autores principales:	Turco, Laura, Schepis, Filippo, Villa, Erica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267399/ https://www.ncbi.nlm.nih.gov/pubmed/31187019 http://dx.doi.org/10.1007/s11901-018-0443-5

Ejemplares similares

The Role of Anticoagulation in Treating Portal Hypertension
por: Turco, Laura, et al.
Publicado: (2018)

Correction: Probiotics (VSL#3) Prevent Endothelial Dysfunction in Rats with Portal Hypertension: Role of the Angiotensin System
Publicado: (2014)

Anticoagulation in the cirrhotic patient
por: Turco, Laura, et al.
Publicado: (2019)

Correction: Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats
por: Gao, Jin-Hang, et al.
Publicado: (2022)

Correction: Recurrent Biliary Obstruction Secondary to Portal Biliopathy and the Role of Cholangioscopy: A Case Report
por: Gebreselassie, Agazi, et al.
Publicado: (2018)

Author Correction: Imaging and Pathological Features of Idiopathic Portal Hypertension and Differential Diagnosis from Liver Cirrhosis
por: Zhao, Zhen-Long, et al.
Publicado: (2020)

Correction: Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review
Publicado: (2021)

Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants
por: Foerster, Kathrin I., et al.
Publicado: (2020)

Correction to: Diagnostic accuracy of spleen stiffness to evaluate portal hypertension and esophageal varices in chronic liver disease: a systematic review and meta-analysis
por: Hu, Xing, et al.
Publicado: (2020)

Anticoagulation in cirrhosis: a new paradigm?
por: Leonardi, Filippo, et al.
Publicado: (2017)

Study of the Serum Metabolomic Profile in Nonalcoholic Fatty Liver Disease: Research and Clinical Perspectives
por: Gitto, Stefano, et al.
Publicado: (2018)

The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD)
por: Carulli, Lucia, et al.
Publicado: (2019)

Retraction: Carulli, L. et al. The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD). Metabolites 2019, 9(2), 25
por: Carulli, Lucia, et al.
Publicado: (2019)

Correction to: Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation
por: Patti, Giuseppe, et al.
Publicado: (2023)

Correction: Patients’ Experiences with and Attitudes towards a Diabetes Patient Web Portal
por: Ronda, Maaike C. M., et al.
Publicado: (2015)

Update on Management of Portal Vein Thrombosis and the Role of Novel Anticoagulants
por: Wu, Matthew, et al.
Publicado: (2019)

Correction: The immunology of hypertension
por: Norlander, Allison E., et al.
Publicado: (2018)

Correction: Anticoagulation Knowledge Tool (AKT): Further evidence of validity in the Italian population
por: Magon, Arianna, et al.
Publicado: (2018)

Correction to: Reversal agents for oral anticoagulant-associated major or life-threatening bleeding
por: Moia, Marco, et al.
Publicado: (2019)

Correction: Uptake of direct oral anticoagulants in primary care: an ecological and economic study
Publicado: (2020)

Correction: A Collision Probability Model of Portal Vein Tumor Thrombus Formation in Hepatocellular Carcinoma
por: Xiong, Fei
Publicado: (2015)

Correction: LCE: an open web portal to explore gene expression and clinical associations in lung cancer
por: Cai, Ling, et al.
Publicado: (2019)

Correction to: Portal flow modulation in living donor liver transplantation: review with a focus on splenectomy
por: Yoshizumi, Tomoharu, et al.
Publicado: (2020)

Correction to: H3ABioNet genomic medicine and microbiome data portals hackathon proceedings
Publicado: (2023)

Correction: Antiplatelets versus Anticoagulants for the Treatment of Cervical Artery Dissection: Bayesian Meta-Analysis
por: Sarikaya, Hakan, et al.
Publicado: (2014)

Correction: Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism
por: Boon, Gudula J. A. M., et al.
Publicado: (2020)

Correction to: The impact on renal function after longterm use of anticoagulants in atrial fibrillation patients
por: Lee, Wei-Chieh, et al.
Publicado: (2021)

Correction: Uncarialines A-E, new alkaloids from Uncaria rhynchophylla and their anticoagulant activity
por: Huang, Ke‑Pu, et al.
Publicado: (2023)

Correction to: Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal‑venous enhancement phase
por: Reinert, Christian Philipp, et al.
Publicado: (2021)

Impenetrable barriers or entry portals? The role of cell–cell adhesion during infection
por: Bonazzi, Matteo, et al.
Publicado: (2011)

Proximal Splenic Artery Embolization to Treat Refractory Ascites in a Patient With Cirrhosis
por: Caporali, Cristian, et al.
Publicado: (2021)

Correction to: Long-term effectiveness and safety of self-management of oral anticoagulants in real-world settings
por: Menéndez-Jándula, Bárbara, et al.
Publicado: (2019)

Correction to: Treatment and outcomes of anticoagulated geriatric trauma patients with traumatic intracranial hemorrhage after falls
por: Nederpelt, Charlie J., et al.
Publicado: (2022)

Correction to: Patients’ usability of seven most used dry-powder inhalers in COPD
por: Dal Negro, Roberto W., et al.
Publicado: (2019)

Portal Hypertension
por: Sun, Mingyu, et al.
Publicado: (2018)

Portale Hypertension
por: Bauer, J., et al.
Publicado: (2011)

Anticoagulation after transjugular intrahepatic portosystemic shunt for portal hypertension: A systematic review and meta analysis
por: Jiao, Pan, et al.
Publicado: (2022)

Correction: Lung and heart-lung transplantation in pulmonary arterial hypertension
por: López-Meseguer, Manuel, et al.
Publicado: (2018)

Correction to: Health-related quality of life in nonvalvular atrial fibrillation patients with controlled or uncontrolled anticoagulation status
por: Varona, José Felipe, et al.
Publicado: (2021)

The role of nitric oxide in portal hypertension caused by extrahepatic portal vein obstruction
por: Goel, P., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ur8rtaor1rv08tvkn1f0go90fp